The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma
Open accessAbstract
Diffuse high-grade gliomas (HGGs) of childhood are a devastating spectrum of disease with no effective cures. The two-year survival for paediatric HGG ranges from 30%, for tumours arising in the cerebral cortex, to less than 10% for diffuse intrinsic pontine gliomas (DIPGs), which arise in the brainstem. Recent genome-wide studies provided abundant evidence that unique selective pressures drive HGG in children compared to adults, identifying novel oncogenic mutations connecting tumorigenesis and chromatin regulation, as well as developmental signalling pathways. These new genetic findings give insights into disease pathogenesis and the challenges and opportunities for improving patient survival in these mostly incurable childhood brain tumours.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Chen, X., Xiu, M., Xing, J., Yu, S., Min, D., & Guo, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479439 · Cited by 5,742
The Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
The Polycomb complex PRC2 and its mark in life
Margueron, R., & Reinberg, D. (2011) · Nature · doi:10.1038/nature09784 · Cited by 3,347
Phillips, H. S., Kharbanda, S., Chen, R., Forrest, W. F., Soriano, R. H., Wu, T. D., Misra, A., Nigro, J. M., Colman, H., Soroceanu, L., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.02.019 · Cited by 3,143
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D. T. W., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D.-A. K., Tönjes, M., et al. (2012) · Nature · doi:10.1038/nature10833 · Cited by 2,631
Sturm, D., Witt, H., Hovestadt, V., Khuong-Quang, D.-A., Jones, D. T. W., Konermann, C., Pfaff, E., Tönjes, M., Sill, M., Bender, S., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.024 · Cited by 1,828
St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project (2012) · Nature Genetics · doi:10.1038/ng.1102 · Cited by 1,724
Killela, P. J., Reitman, Z. J., Jiao, Y., Bettegowda, C., Agrawal, N., Diaz, L. A., Friedman, A. H., Friedman, H., Gallia, G. L., Giovanella, B. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303607110 · Cited by 1,368
Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma
Lewis, P. W., Müller, M. M., Koletsky, M. S., Cordero, F., Lin, S., Banaszynski, L. A., Garcia, B. A., Muir, T. W., Becher, O. J., & Allis, C. D. (2013) · Science · doi:10.1126/science.1232245 · Cited by 1,345
PTEN and the PI3-Kinase Pathway in Cancer
Chalhoub, N., & Baker, S. J. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092311 · Cited by 1,245
Self-citationShore, E. M., Xu, M., Feldman, G. J., Fenstermacher, D. A., Cho, T.-J., Choi, I. H., Connor, J. M., Delai, P., Glaser, D. L., LeMerrer, M., et al. (2006) · Nature Genetics · doi:10.1038/ng1783 · Cited by 1,215
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells
Piccirillo, S. G. M., Reynolds, B. A., Zanetti, N., Lamorte, G., Binda, E., Broggi, G., Brem, H., Olivi, A., Dimeco, F., & Vescovi, A. L. (2006) · Nature · doi:10.1038/nature05349 · Cited by 1,176
the St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project (2014) · Nature Genetics · doi:10.1038/ng.2938 · Cited by 1,105
Schindler, G., Capper, D., Meyer, J., Janzarik, W., Omran, H., Herold-Mende, C., Schmieder, K., Wesseling, P., Mawrin, C., Hasselblatt, M., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0802-6 · Cited by 1,034
Khuong-Quang, D.-A., Buczkowicz, P., Rakopoulos, P., Liu, X.-Y., Fontebasso, A. M., Bouffet, E., Bartels, U., Albrecht, S., Schwartzentruber, J., Letourneau, L., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0998-0 · Cited by 1,028
Understanding the language of Lys36 methylation at histone H3
Wagner, E. J., & Carpenter, P. B. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3274 · Cited by 936
Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone
Behjati, S., Tarpey, P. S., Presneau, N., Scheipl, S., Pillay, N., Van Loo, P., Wedge, D. C., Cooke, S. L., Gundem, G., Davies, H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2814 · Cited by 854
Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
the St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project (2013) · Nature Genetics · doi:10.1038/ng.2611 · Cited by 835
Subtypes of medulloblastoma have distinct developmental origins
Gibson, P., Tong, Y., Robinson, G., Thompson, M. C., Currle, D. S., Eden, C., Kranenburg, T. A., Hogg, T., Poppleton, H., Martin, J., et al. (2010) · Nature · doi:10.1038/nature09587 · Cited by 831
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma
the International Cancer Genome Consortium PedBrain Tumor Project, Jones, D. T. W., Hutter, B., Jäger, N., Korshunov, A., Kool, M., Warnatz, H.-J., Zichner, T., Lambert, S. R., Ryzhova, M., et al. (2013) · Nature Genetics · doi:10.1038/ng.2682 · Cited by 825
Bender, S., Tang, Y., Lindroth, A. M., Hovestadt, V., Jones, D. T. W., Kool, M., Zapatka, M., Northcott, P. A., Sturm, D., Wang, W., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.10.006 · Cited by 818
Self-citationMosaic Amplification of Multiple Receptor Tyrosine Kinase Genes in Glioblastoma
Snuderl, M., Fazlollahi, L., Le, L. P., Nitta, M., Zhelyazkova, B. H., Davidson, C. J., Akhavanfard, S., Cahill, D. P., Aldape, K. D., Betensky, R. A., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.11.005 · Cited by 707
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression
Chan, K.-M., Fang, D., Gan, H., Hashizume, R., Yu, C., Schroeder, M., Gupta, N., Mueller, S., James, C. D., Jenkins, R., et al. (2013) · Genes & Development · doi:10.1101/gad.217778.113 · Cited by 707
Paugh, B. S., Qu, C., Jones, C., Liu, Z., Adamowicz-Brice, M., Zhang, J., Bax, D. A., Coyle, B., Barrow, J., Hargrave, D., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.7252 · Cited by 654
Self-citationBuczkowicz, P., Hoeman, C., Rakopoulos, P., Pajovic, S., Letourneau, L., Dzamba, M., Morrison, A., Lewis, P., Bouffet, E., Bartels, U., et al. (2014) · Nature Genetics · doi:10.1038/ng.2936 · Cited by 647
Self-citationDiffuse brainstem glioma in children: critical review of clinical trials
Hargrave, D., Bartels, U., & Bouffet, E. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70615-5 · Cited by 634
Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge
Sturm, D., Bender, S., Jones, D. T. W., Lichter, P., Grill, J., Becher, O., Hawkins, C., Majewski, J., Jones, C., Costello, J. F., et al. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3655 · Cited by 555
Self-citationSzerlip, N. J., Pedraza, A., Chakravarty, D., Azim, M., McGuire, J., Fang, Y., Ozawa, T., Holland, E. C., Huse, J. T., Jhanwar, S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114033109 · Cited by 538
Yan, H., Killela, P. J., Reitman, Z. J., Jiao, Y., Bettegowda, C., Agrawal, N., Diaz, L. A., Friedman, A. H., Friedman, H., Gallia, G. L., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou206.18 · Cited by 529
The integrated landscape of driver genomic alterations in glioblastoma
Frattini, V., Trifonov, V., Chan, J. M., Castano, A., Lia, M., Abate, F., Keir, S. T., Ji, A. X., Zoppoli, P., Niola, F., et al. (2013) · Nature Genetics · doi:10.1038/ng.2734 · Cited by 524
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
Taylor, K. R., Mackay, A., Truffaux, N., Butterfield, Y. S., Morozova, O., Philippe, C., Castel, D., Grasso, C. S., Vinci, M., Carvalho, D., et al. (2014) · Nature Genetics · doi:10.1038/ng.2925 · Cited by 517
Self-citationDi Lorenzo, A., & Bedford, M. T. (2011) · FEBS Letters · doi:10.1016/j.febslet.2010.11.010 · Cited by 509
Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma
Fontebasso, A. M., Papillon-Cavanagh, S., Schwartzentruber, J., Nikbakht, H., Gerges, N., Fiset, P.-O., Bechet, D., Faury, D., De Jay, N., Ramkissoon, L. A., et al. (2014) · Nature Genetics · doi:10.1038/ng.2950 · Cited by 465
Histone lysine demethylases as targets for anticancer therapy
Højfeldt, J. W., Agger, K., & Helin, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4154 · Cited by 455
Plass, C., Pfister, S. M., Lindroth, A. M., Bogatyrova, O., Claus, R., & Lichter, P. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3554 · Cited by 453
Epigenetic programming and reprogramming during development
Cantone, I., & Fisher, A. G. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2489 · Cited by 437
Lee, J., Son, M. J., Woolard, K., Donin, N. M., Li, A., Cheng, C. H., Kotliarova, S., Kotliarov, Y., Walling, J., Ahn, S., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.005 · Cited by 429
Zhang, H., Li, D., Zhao, L., Fleming, J., Lin, N., Wang, T., Liu, Z., Li, C., Galwey, N., Deng, J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2735 · Cited by 429
Knezevich, S. R., Garnett, M. J., Pysher, T. J., Beckwith, J. B., Grundy, P. E., & Sorensen, P. H. B. (1998) · PubMed · Cited by 412
The double face of the histone variant H3.3
Szenker, E., Ray-Gallet, D., & Almouzni, G. (2011) · Cell Research · doi:10.1038/cr.2011.14 · Cited by 391
Epigenetic control of neural precursor cell fate during development
Hirabayashi, Y., & Gotoh, Y. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2810 · Cited by 375
Cross-species genomics matches driver mutations and cell compartments to model ependymoma
Johnson, R. A., Wright, K. D., Poppleton, H., Mohankumar, K. M., Finkelstein, D., Pounds, S. B., Rand, V., Leary, S. E. S., White, E., Eden, C., et al. (2010) · Nature · doi:10.1038/nature09173 · Cited by 367
Maze, I., Noh, K.-M., Soshnev, A. A., & Allis, C. D. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3673 · Cited by 349
Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma
Monje, M., Mitra, S. S., Freret, M. E., Raveh, T. B., Kim, J., Masek, M., Attema, J. L., Li, G., Haddix, T., Edwards, M. S. B., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101657108 · Cited by 348
Paugh, B. S., Broniscer, A., Qu, C., Miller, C. P., Zhang, J., Tatevossian, R. G., Olson, J. M., Geyer, J. R., Chi, S. N., da Silva, N. S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.5677 · Cited by 320
Self-citationHistone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN
Bjerke, L., Mackay, A., Nandhabalan, M., Burford, A., Jury, A., Popov, S., Bax, D. A., Carvalho, D., Taylor, K. R., Vinci, M., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0426 · Cited by 318
Self-citationZarghooni, M., Bartels, U., Lee, E., Buczkowicz, P., Morrison, A., Huang, A., Bouffet, E., & Hawkins, C. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.5463 · Cited by 313
Prospective study of awake craniotomy used routinely and nonselectively for supratentorial tumors
Serletis, D., & Bernstein, M. (2007) · Journal of Neurosurgery · doi:10.3171/jns-07/07/0001 · Cited by 312
Diffuse intrinsic pontine glioma: poised for progress
Warren, K. E. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00205 · Cited by 297
Fontebasso, A. M., Schwartzentruber, J., Khuong-Quang, D.-A., Liu, X.-Y., Sturm, D., Korshunov, A., Jones, D. T. W., Witt, H., Kool, M., Albrecht, S., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1095-8 · Cited by 290
Fusion of ETV6 to Neurotrophin-3 Receptor TRKC in Acute Myeloid Leukemia With t(12;15)(p13;q25)
Eguchi, M., Eguchi-Ishimae, M., Tojo, A., Morishita, K., Suzuki, K., Sato, Y., Kudoh, S., Tanaka, K., Setoyama, M., Nagamura, F., et al. (1999) · Blood · doi:10.1182/blood.v93.4.1355 · Cited by 281
Gomes, W. A., Mehler, M. F., & Kessler, J. A. (2003) · Developmental Biology · doi:10.1016/s0012-1606(02)00037-4 · Cited by 279
Schiffman, J. D., Hodgson, J. G., VandenBerg, S. R., Flaherty, P., Polley, M.-Y. C., Yu, M., Fisher, P. G., Rowitch, D. H., Ford, J. M., Berger, M. S., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1851 · Cited by 251
Paediatric and adult malignant glioma: close relatives or distant cousins?
Jones, C., Perryman, L., & Hargrave, D. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.87 · Cited by 243
Self-citationPuget, S., Philippe, C., Bax, D. A., Job, B., Varlet, P., Junier, M.-P., Andreiuolo, F., Carvalho, D., Reis, R., Guerrini-Rousseau, L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030313 · Cited by 242
Self-citationClinical and Molecular Characteristics of Malignant Transformation of Low-Grade Glioma in Children
Broniscer, A., Baker, S. J., West, A. N., Fraser, M. M., Proko, E., Kocak, M., Dalton, J., Zambetti, G. P., Ellison, D. W., Kun, L. E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.8213 · Cited by 237
Self-citationNovel Oncogenic PDGFRA Mutations in Pediatric High-Grade Gliomas
Paugh, B. S., Zhu, X., Qu, C., Endersby, R., Diaz, A. K., Zhang, J., Bax, D. A., Carvalho, D., Reis, R. M., Onar-Thomas, A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1491 · Cited by 235
Self-citationVenneti, S., Garimella, M. T., Sullivan, L. M., Martinez, D., Huse, J. T., Heguy, A., Santi, M., Thompson, C. B., & Judkins, A. R. (2013) · Brain Pathology · doi:10.1111/bpa.12042 · Cited by 235
Qaddoumi, I., Sultan, I., & Gajjar, A. (2009) · Cancer · doi:10.1002/cncr.24663 · Cited by 218
Shen, Q., Little, S. C., Xu, M., Haupt, J., Ast, C., Katagiri, T., Mundlos, S., Seemann, P., Kaplan, F. S., Mullins, M. C., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37412 · Cited by 216
Distinct Neural Stem Cell Populations Give Rise to Disparate Brain Tumors in Response to N-MYC
Swartling, F. J., Savov, V., Persson, A. I., Chen, J., Hackett, C. S., Northcott, P. A., Grimmer, M. R., Lau, J., Chesler, L., Perry, A., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.012 · Cited by 215
H3F3A K27M mutations in thalamic gliomas from young adult patients
Aihara, K., Mukasa, A., Gotoh, K., Saito, K., Nagae, G., Tsuji, S., Tatsuno, K., Yamamoto, S., Takayanagi, S., Narita, Y., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not144 · Cited by 199
New functions for an old variant: no substitute for histone H3.3
Elsässer, S. J., Goldberg, A. D., & Allis, C. D. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.01.003 · Cited by 196
Chaikuad, A., Alfano, I., Kerr, G., Sanvitale, C. E., Boergermann, J. H., Triffitt, J. T., von Delft, F., Knapp, S., Knaus, P., & Bullock, A. N. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.365932 · Cited by 180
Zhao, H., Ayrault, O., Zindy, F., Kim, J.-H., & Roussel, M. F. (2008) · Genes & Development · doi:10.1101/gad.1636408 · Cited by 170
Lannon, C. L., & Sorensen, P. H. B. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.01.003 · Cited by 166
Histone variants in pluripotency and disease
Skene, P. J., & Henikoff, S. (2013) · Development · doi:10.1242/dev.091439 · Cited by 164
Barton, K. L., Misuraca, K., Cordero, F., Dobrikova, E., Min, H. D., Gromeier, M., Kirsch, D. G., & Becher, O. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077639 · Cited by 162
Walker, D. A., Liu, J., Kieran, M., Jabado, N., Picton, S., Packer, R., St. Rose, C., (on behalf of the CPN Paris 2011 Conference Consensus Group), Van Meeteren, A. S., Carvalho, A., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/nos330 · Cited by 162
Self-citationA Distinct Spectrum of Copy Number Aberrations in Pediatric High-Grade Gliomas
Bax, D. A., Mackay, A. G., Little, S. E., Carvalho, D. M., Viana‐Pereira, M., Tamber, N., Grigoriadis, A. E., Ashworth, A., Reis, R. M., Ellison, D. W., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0438 · Cited by 160
Self-citationGeoerger, B., Hargrave, D., Thomas, F., Ndiaye, A., Frappaz, D., Andreiuolo, F., Varlet, P., Aerts, I., Riccardi, R., Jaspan, T., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/noq141 · Cited by 159
Targeted Therapy for BRAFV600E Malignant Astrocytoma
Nicolaides, T. P., Li, H., Solomon, D. A., Hariono, S., Hashizume, R., Barkovich, K. J., Baker, S. J., Paugh, B. S., Jones, C., Forshew, T., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1456 · Cited by 154
Self-citationHistone H3.3 Mutations: A Variant Path to Cancer
Yuen, B. T. K., & Knoepfler, P. S. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.09.015 · Cited by 148
Vemurafenib in pediatric patients with BRAFV 600E mutated high‐grade gliomas
Bautista, F. J., Paci, A., Minard‐Colin, V., Dufour, C., Grill, J., Lacroix, L., Varlet, P., Valteau‐Couanet, D., & Geoerger, B. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24891 · Cited by 148
New Strategies in Neuroblastoma: Therapeutic Targeting of MYCN and ALK
Barone, G., Anderson, J., Pearson, A. D. J., Petrie, K. R., & Chesler, L. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0680 · Cited by 144
Li, Z., Tognon, C. E., Godinho, F. J., Yasaitis, L. C., Hock, H. R., Herschkowitz, J. I., Lannon, C. L., Cho, E., Kim, S., Bronson, R. T., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.11.012 · Cited by 138
Navigating the epigenetic landscape of pluripotent stem cells
Li, M., Liu, G., & Belmonte, J. C. I. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3393 · Cited by 127
Little, S. E., Popov, S., Jury, A., Bax, D. A., Doey, L. J., Al‐Sarraj, S., Jürgensmeier, J. M., & Jones, C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4069 · Cited by 123
Self-citationSubstance P signaling mediates BMP-dependent heterotopic ossification
Kan, L., Lounev, V. Y., Pignolo, R. J., Duan, L., Liu, Y., Stock, S. R., McGuire, T. L., Lu, B., Gerard, N. P., Shore, E. M., et al. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23259 · Cited by 121
Barrow, J., Adamowicz‐Brice, M., Cartmill, M., Macarthur, D., Lowe, J. S., Robson, K., Bründler, M., Walker, D. A., Coyle, B., & Grundy, R. G. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq158 · Cited by 116
Qu, H., Jacob, K., Fattet, S., Ge, B., Barnett, D., Delattre, O., Faury, D., Montpetit, A., Solomon, L. A., Hauser, P., et al. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop001 · Cited by 105
Constitutively Active ALK2 Receptor Mutants Require Type II Receptor Cooperation
Bagarova, J., Vonner, A. J., Armstrong, K. A., Boergermann, J. H., Lai, C. S. C., Deng, D. Y., Beppu, H., Alfano, I., Filippakopoulos, P., Morrell, N. W., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01595-12 · Cited by 93
Huillard, E., Hashizume, R., Phillips, J. J., Griveau, A., Ihrie, R. A., Aoki, Y., Nicolaides, T. P., Perry, A., Waldman, T. A., McMahon, M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117255109 · Cited by 87
Thalamic high-grade gliomas in children: a distinct clinical subset?
Kramm, C. M., Butenhoff, S., Rausche, U., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor045 · Cited by 81
Broniscer, A., Baker, J. N., Baker, S. J., Chi, S. N., Geyer, J. R., Morris, E. B., & Gajjar, A. J. (2010) · Cancer · doi:10.1002/cncr.25405 · Cited by 77
Self-citationMorphologic Characteristics and Immunohistochemical Profile of Diffuse Intrinsic Pontine Gliomas
Ballester, L. Y., Wang, Z., Shandilya, S., Miettinen, M., Burger, P. C., Eberhart, C. G., Rodríguez, F. J., Raabe, E. H., Nazarian, J., Warren, K. E., et al. (2013) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318294e817 · Cited by 72
Post mortem examinations in diffuse intrinsic pontine glioma: challenges and chances
Angelini, P., Hawkins, C. E., Laperrière, N., Bouffet, É., & Bartels, U. K. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0224-7 · Cited by 65
Fibrodysplasia ossificans progressiva: a blueprint for metamorphosis
Kaplan, F. S., Lounev, V. Y., Wang, H., Pignolo, R. J., & Shore, E. M. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06195.x · Cited by 35
Cerebellar location may predict an unfavourable prognosis in paediatric high-grade glioma
Karremann, M., Rausche, U., Roth, D., Kühn, A., Pietsch, T., Gielen, G. H., Warmuth‐Metz, M., Kortmann, R.-D., Straeter, R., Gnekow, A., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.404 · Cited by 32
Baker, J. N., Windham, J., Hinds, P. S., Gattuso, J. S., Mandrell, B. N., Gajjar, P., West, N. K., Hammarback, T., & Broniscer, A. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.01.015 · Cited by 30
Cited by
Ostrom, Q. T., Cioffi, G., Gittleman, H., Patil, N., Waite, K., Kruchko, C., & Barnholtz-Sloan, J. S. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz150 · Cited by 2,585
Ostrom, Q. T., Cioffi, G., Waite, K., Kruchko, C., & Barnholtz-Sloan, J. S. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab200 · Cited by 2,529
Ostrom, Q. T., Gittleman, H., Truitt, G., Boscia, A., Kruchko, C., & Barnholtz-Sloan, J. S. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy131 · Cited by 2,138
Ostrom, Q. T., Gittleman, H., Liao, P., Vecchione-Koval, T., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. S. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox158 · Cited by 1,800
Ostrom, Q. T., Patil, N., Cioffi, G., Waite, K., Kruchko, C., & Barnholtz-Sloan, J. S. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa200 · Cited by 1,789
Metadata
- Authors
- Jones, C., & Baker, S. J.
- Venue
- Nature Reviews Cancer
- Published
- 2014-09-18
- Volume
- 14
- Issue
- 10
- Pages
- 651-661
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1989297227
- Cited by
- 298
- References
- 97
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.